Genome-Wide-Association Studies (GWAS) require large-scale cohorts with both phenotype and genetic sequencing data, which has limited studied phenotypes. In this session, Zachary Levine from the Weizmann Institute of Science will delve into the outcomes of their GWAS and PRS-PheWAS involving 727 clinical phenotypes and 4,045 molecular features from the Human Phenotype Project. Join us to learn more about previously unlinked clinical traits and the study's utilization of low-pass whole genome sequencing, which has brought forth fresh insights into the intricate genetic architecture governing complex human phenotypes